Literature DB >> 15188175

Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking.

Razao Issa1, Xiaoying Zhou, Christothea M Constandinou, Jonathan Fallowfield, Harry Millward-Sadler, Marianna D A Gaca, Emma Sands, Ibnauf Suliman, Nathan Trim, Andreas Knorr, Michael J P Arthur, R Christopher Benyon, John P Iredale.   

Abstract

BACKGROUND & AIMS: Liver fibrosis and cirrhosis result from the excessive secretion of matrix proteins by hepatic stellate cells (HSCs). Previously considered irreversible, we have studied a model of cirrhosis to determine the mechanisms mediating and limiting spontaneous recovery.
METHODS: A micronodular cirrhosis was induced in rats after 12 weeks of CCl(4) intoxication. Livers were analyzed for evidence of matrix degradation, matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) expression, stellate cell apoptosis, tissue transglutaminase (tTg) expression, and matrix cross-linking during spontaneous recovery of up to 366 days.
RESULTS: Over 366 days of recovery, micronodular cirrhosis underwent significant remodeling to a macronodular cirrhosis. Expression of collagen-1 and TIMP messenger RNA (mRNA) decreased significantly and active MMPs were shown in livers during remodeling of fibrosis. Resolution also was characterized by apoptosis of HSCs, predominantly at the margins of fibrotic septa. Residual septa, not remodeled at 366 days, were characterized by tTg-mediated cross-linking and relative hypocellularity.
CONCLUSION: Recovery from comparatively advanced cirrhosis is possible and results in remodeling from a micronodular cirrhosis to a macronodular cirrhosis. We suggest resolution is limited by tTg-mediated matrix cross-linking and a failure of HSC apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188175     DOI: 10.1053/j.gastro.2004.03.009

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  125 in total

1.  Holeuryhalinity and its mechanisms in a cirriped crustacean, Balanus improvisus.

Authors:  H J Fyhn
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1976-01

Review 2.  Liver fibrosis: a bidirectional model of fibrogenesis and resolution.

Authors:  P Ramachandran; J P Iredale
Journal:  QJM       Date:  2012-05-29

Review 3.  Targeting Hepatic Fibrosis in Autoimmune Hepatitis.

Authors:  Aldo J Montano-Loza; Ragesh B Thandassery; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-19       Impact factor: 3.199

4.  Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis.

Authors:  Scott L Friedman
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

5.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

Authors:  Jeremy S Duffield; Stuart J Forbes; Christothea M Constandinou; Spike Clay; Marina Partolina; Srilatha Vuthoori; Shengji Wu; Richard Lang; John P Iredale
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

Review 6.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.

Authors:  Thomas A Wynn
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 7.  Extracellular matrix and liver disease.

Authors:  Elena Arriazu; Marina Ruiz de Galarreta; Francisco Javier Cubero; Marta Varela-Rey; María Pilar Pérez de Obanos; Tung Ming Leung; Aritz Lopategi; Aitor Benedicto; Ioana Abraham-Enachescu; Natalia Nieto
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

8.  EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling.

Authors:  Sang-A Park; Min-Jin Kim; So-Yeon Park; Jung-Shin Kim; Seon-Joo Lee; Hyun Ae Woo; Dae-Kee Kim; Jeong-Seok Nam; Yhun Yhong Sheen
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

9.  Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in vitro and prevents liver fibrosis in vivo.

Authors:  Chunqiu Hao; Yumei Xie; Meijuan Peng; Li Ma; Yun Zhou; Yan Zhang; Wenzhen Kang; Jiuping Wang; Xuefan Bai; Pingzhong Wang; Zhansheng Jia
Journal:  Clin Exp Med       Date:  2013-03-02       Impact factor: 3.984

10.  Using immunoproteomics to identify alpha-enolase as an autoantigen in liver fibrosis.

Authors:  Bo Peng; Xueyong Huang; Ernesto S Nakayasu; John R Petersen; Suimin Qiu; Igor C Almeida; Jian-Ying Zhang
Journal:  J Proteome Res       Date:  2013-03-15       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.